Mouse Embryonic Fibroblasts Reprogramming to Induced Pluripotent Stem Cells by T3

Area of Science:

• Stem cell biology
• Molecular biology
• Endocrinology

Background:

• Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) using specific transcription factors (Yamanaka factors).
• Optimizing reprogramming efficiency is crucial for advancing regenerative medicine and disease modeling.

Purpose of the Study:

• To present a protocol for enhancing induced pluripotent stem cell (iPSC) generation from mouse embryonic fibroblasts (MEFs) using triiodo-L-thyronine (T3).
• To describe methods for analyzing iPSC pluripotency, including alkaline phosphatase staining and gene expression profiling.

Main Methods:

• Reprogramming of MEFs using retroviral delivery of Yamanaka factors, with the addition of triiodo-L-thyronine (T3).
• Colony staining for alkaline phosphatase activity to identify pluripotent stem cells.
• Quantitative real-time PCR (qPCR) to analyze endogenous pluripotency gene expression in expanded iPSC colonies.

Main Results:

• Triiodo-L-thyronine (T3) supplementation enhances the efficiency of induced pluripotent stem cell (iPSC) generation.
• Established iPSC colonies exhibit alkaline phosphatase activity, confirming pluripotency.
• Gene expression analysis confirms the endogenous expression of key pluripotency markers in T3-enhanced iPSCs.

Conclusions:

• Integrating triiodo-L-thyronine (T3) into reprogramming protocols offers a significant improvement in induced pluripotent stem cell (iPSC) production.
• This enhanced method facilitates the generation of functional iPSCs, supporting research in cell plasticity, disease modeling, and regenerative therapies.